Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops
Completed
Conditions studied: Glaucoma
In brief
This study examines patient perceptions regarding the tolerability of two classes of glaucoma medication: bimatoprost and latanoprost.
Key facts
- Study ID
- NCT02138461
- Run by
- MDbackline, LLC
- People needed
- 211
- Starts
- 2013-10-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2014-09-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with glaucoma taking either bimatoprost or latanoprost
You may not qualify if…
- patients taking other medication or with other causes for ocular surface symptoms
Where it is running
- Harvard Eye Associates — Laguna Hills, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.